FOR THE NEXT GENERATION OF PHYSICIANS
← All USMLE guides
HEMATOLOGY AND ONCOLOGY

Anticoagulants: heparin, warfarin, DOACs and reversal.

Mechanism, monitoring and reversal of heparin, warfarin and direct oral anticoagulants, with warfarin interactions and pregnancy use.

Anticoagulant questions test monitoring and antidotes. Each drug has a lab and a reversal agent.

Heparin

Enhances antithrombin; monitored with PTT. Reverse with protamine sulfate. Low-molecular-weight heparin is monitored with anti-Xa when needed and is safe in pregnancy; warfarin is teratogenic.

Warfarin

Inhibits vitamin K epoxide reductase, reducing factors II, VII, IX and X and proteins C and S; monitored with INR. Initial protein C depletion can cause warfarin skin necrosis, so bridge with heparin. Reverse with vitamin K, and with prothrombin complex concentrate or fresh frozen plasma for major bleeding.

DOACs

Dabigatran is a direct thrombin inhibitor reversed with idarucizumab. Rivaroxaban and apixaban inhibit factor Xa and are reversed with andexanet alfa or prothrombin complex concentrate. Fibrinolytics (alteplase) convert plasminogen to plasmin; aminocaproic acid counters them.

Keep going in hematology and oncology

Related on USMLE WEB

Frequently asked questions

How is heparin reversed?

Protamine sulfate.

What is the antidote for dabigatran?

Idarucizumab.